Clinical Trials in Atlanta

Showing 5301-5320 of 14,993 trials

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

NCT06337331

Patients eligible for a mismatch allogeneic stem cell transplant will receive Venetoclax daily for 7 days prior to transplant in addition to the following chemotherapy regimen: Decitabine daily for 5 days, Fludarabine daily for 5 days, and Busulfan daily for 2 days followed by 1 day of total body irradiation. Stem cell transplant will occur thereafter.

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Northside Hospital, Inc.Started Aug 2024

Atlanta, Georgia, United States

COMPLETEDPhase 4< 1 mile

Dapagliflozin at Discharge on Hospital Heart Failure Readmission

NCT04249778

This study will evaluate the safety and efficacy of dapagliflozin treatment in preventing hospital re-admissions, emergency room (ER) visits, urgent clinic visits, and death in patients with and without type 2 diabetes (T2D) after hospital admission for heart failure.

Heart FailureDiabetes

Emory University105 participantsStarted Jul 2020

Atlanta, Georgia, United States • New Orleans, Louisiana, United States • Philadelphia, Pennsylvania, United States

TERMINATEDPhase 1/2< 1 mile

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

NCT04161391

A phase 1/2, first-in-human, open-label study to determine the safety, tolerability, PK, and preliminary efficacy of the novel RET/SRC inhibitor TPX-0046 in adult subjects with advanced or metastatic solid tumors harboring RET mutations or alterations. The study consists of three portions: 1) Phase 1 Dose Escalation and Food Effect Sub-study, and 2) Phase 1 dose expansion and 3) Phase 2 efficacy evaluation.

Non Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more

Turning Point Therapeutics, Inc.41 participantsStarted Dec 2019

La Jolla, California, United States • Orange, California, United States • Aurora, Colorado, United States +18 more locations

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Dapagliflozin at Discharge on Hospital Heart Failure Readmission

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Find Trials by Condition in Atlanta

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria